Filing Details

Accession Number:
0001144204-13-015638
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-18 11:11:12
Reporting Period:
2013-03-15
Filing Date:
2013-03-18
Accepted Time:
2013-03-18 11:11:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
810509 Navidea Biopharmaceuticals Inc. NAVB In Vitro & In Vivo Diagnostic Substances (2835) 311080091
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1559381 J. William Regan 425 Metro Place North
Suite 450
Dublin OH 43017
Svp-Global Regulatory Strategy No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-03-15 5,000 $2.71 5,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct